The Cleaning Validation Process
|
|
- Job Kelley
- 6 years ago
- Views:
Transcription
1 The Cleaning Validation Process The Scope of Cleaning Validation The Cleaning Validation Sequence Prerequisites Cleaning Validation Strategy, Plan, and Policy Sampling Recovery Studies Analytical Method Selection and Development Analytical Method Validation Acceptance Criteria Cleaning Method Development Validation Master Plan Cleaning Validation Plan 15
2 Cleaning Process Standard Operating Procedures (SOPs) Cleaning Validation Protocols Protocol Execution Clean and Dirty Hold Times Validation Report Post Validation Monitoring Maintaining the Validated Status Retrospective Cleaning Validation Glossary What You Learned 16
3 The Scope Of Cleaning Validation Normally, only cleaning procedures for surfaces of the equipment that come into contact with product need to be validated. To be more effective, however, programs for the elimination of crosscontamination must also address non-product contact surfaces. When establishing prerequisites for non-product contact surfaces, you must review the probable interactions of those areas. Cleaning validation is usually only needed for critical cleaning, e.g. between manufacturing of one product and a different product and is not normally necessarily for non-critical cleaning such as between batches of the same product (or different lots of the same intermediate in a bulk process). In API manufacturing, it may be unnecessary to validate equipment cleaning where residues are removed by subsequent purification steps. Products that simulate the physiochemical properties of the substance to be removed may be used instead of the substances themselves, where such substances are toxic or hazardous. The intervals between use and cleaning, as well as cleaning and reuse, 17
4 should also be validated. Cleaning intervals and methods should be determined. It is the responsibility of the manufacturer to demonstrate that the level of cleaning and validation performed is adequate based on each individual situation and on a justifiable scientific rational. Microbiological aspects should be considered, although they should consist largely of preventative measures rather than the removal of contamination once it has occurred. (WHO) 18
5 The Cleaning Validation Sequence CLEANING VALIDATION PROCESS (Prospective) Cleaning Validation Strategy Process & Product Development Validation Master Plan Analytical Methods Identified / Developed Cleaning Agents & Methods Identified Analytical Methods Validated Cleaning Method Developed Recovery Studied Completed Sample technique and Methods of Detection identified Establishment of Acceptable Levels of Carry-over Refining Acceptable Levels of carry-over Cleaning VP Cleaning SOPs Created Cleaning Validation Protocol Validation Summary Report Execution of Protocol Revalidation 19
6 Pre-requisites Before beginning cleaning validation, the following should be available and completed: Agreed company strategy and policy; Cleaning methodology; Defined sampling methodology; Completed analytical method selection / development; Validation of analytical methods; Defined acceptance criteria; Validation Master Plan; Cleaning Validation (Master) Plan; Creation of related SOPs; Cleaning Validation Protocol. 20
7 Cleaning Validation Strategy, Plan & Policy The cleaning validation policy should incorporate the following: A statement specifying what company policy is on validation of cleaning procedures related to equipment (including ancillary) and processes, such as: Cleaning only after product changeover or between batches in campaigns; Cleaning of major and minor equipment; Company policy on the dedication of all equipment for each product, (if products are deemed too dangerous and / or highly active to manufacture on multi-product equipment); Company policy on the grouping of products or equipment such as: Validate the cleaning of each product individually; Bracketing / grouping products for cleaning validation; Bracketing / grouping equipment for cleaning validation; Selection of worst case products; Sampling Methodology to be used; Analytical validation policy; The rational for the methods by which acceptance criteria is 21
8 determined; Revalidation policy; Glossary / Definition of terms employed during validation (for example, rinse, flush, wash and so on). Campaign Production and Batch Production Campaign production always helps in minimizing cross-contamination issues between lots. In a multiple-product facility, campaign lots of a single product or product family are produced in the same equipment. At times, the production run may be stopped for a partial cleanup of the equipment, which is less stringent than a full cleanup. Once the campaign production is over, an intensive cleaning of the facility and equipment can be performed before starting production of a different product. Minor and Major Equipment Although there is no such terminology as minor equipment in current good manufacturing practices (cgmps), items such as utensils may be regarded as minor equipment. Major equipment represents those that play a central role in production processes. Typically, the cleaning of major equipment will be the subject of specific standard operating procedures (SOPs) and it is important to differentiate those pieces of equipment that are central to the production process from those that perform a secondary role (utensils). 22
Manual: 038. Cleaning and Cleaning Validation of API Plant and Equipment
Title: Cleaning and Cleaning Validation of API Plant and Equipment Manual Number: 38 Prepared by: Date: Supersedes: Checked by: Date: Date Issued: Approved by: Date: Review Date: Manual: 38 Cleaning and
More informationRegulatory Aspects of Cleaning and Cleaning Validation. Larry Greenstein Quality Operations, Quality Unit, Bio-Technology General, Ltd.
Regulatory Aspects of Cleaning and Cleaning Validation Larry Greenstein Quality Operations, Quality Unit, Bio-Technology General, Ltd. 28 June 2017 Why clean? Pharmaceutical production equipment is cleaned
More informationOverview of Cleaning Validation in Pharmaceutical Industry
Overview of Cleaning Validation in Pharmaceutical Industry 1 Pankaj P Chandra Treya, 2 Dr. D N Jhade 1 Research Scholar, SSSUTMS, Sehore 2 Research Guide, SSSUTMS, Sehore Abstract Manufacturing of Pharmaceutical
More informationContents. Contents (13) 1 Qualification (21)
1 Qualification (21) 1.A Official requirements (23) 1.A.1 Legal aspects of qualification (23) 1.A.2 Documentation of the qualification (26) 1.A.3 Design Qualification (DQ) (27) 1.A.4 Installation Qualification
More informationGUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PH 1/97 (Rev. 3), 15 January 2002 ANNEX 15 QUALIFICATION AND
More informationSystems-Based Inspections for Cleaning Validation
Systems-Based Inspections for Cleaning Validation FDA DG 230 July 21, 2014 Rockville, MD Destin A. LeBlanc Cleaning Validation Technologies www.cleaningvalidation.com 1 Cleaning Definition: The process
More informationCleaning Procedures. These guidelines are intended for Bulk Pharmaceutical Chemicals but almost every word applies to Drug Products
CLEANING DEVELOPMENT Cleaning Procedures as the FDA See It These guidelines are intended for Bulk Pharmaceutical Chemicals but almost every word applies to Drug Products BPC CLEANING (& Drug Products)
More informationCleaning and Cleaning Validation of API Plant and Equipment
Regulatory Basis: FDA Quality Systems Regulations Reference: FDA CFR - Code of Federal Regulations Title 21 1 Purpose The purpose of this guideline is: To define the requirements for cleaning plant and
More informationSystems-Based Inspections for Cleaning Validation
Systems-Based Inspections for Cleaning Validation FDA DG 230 July 27, 2015 Rockville, MD Destin A. LeBlanc Cleaning Validation Technologies www.cleaningvalidation.com 1 Objectives Describe and/or identify:
More informationCOMPLIANCE WITH EU ANNEX 15: VALIDATION AND QUALIFICATION
COMPLIANCE WITH EU ANNEX 15: VALIDATION AND QUALIFICATION Paul L. Pluta, PhD Journal of Validation Technology Journal of GXP Compliance University of Illinois at Chicago (UIC) College of Pharmacy, Chicago,
More informationWorld Journal of Pharmaceutical Research SJIF Impact Factor 5.990
SJIF Impact Factor 5.990 Volume 4, Issue 9, 421-436. Review Article ISSN 2277 7105 CLEANING VALIDATION OF PHARMACEUTICAL DOSAGE FORMS Gupta Mamta* and Bharkatiya Meenakshi B.N. Institute of Pharmaceutical
More informationJournal of Atoms and Molecules
Review article Journal of Atoms and Molecules An International Online Journal ISSN 2277 1247 CLEANING VALIDATION IN PHARMACEUTICAL INDUSTRIES Abhishek Raj Senior R&D Officer, Quest Pharmaceuticals Pvt.
More informationPROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D.
Basic GMP Requirement PROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D. Topic Process validation What and Why? Principle of process validation Manufacturing process validation Aseptic process validation
More informationAnnex Draft Annex
Anmerkung 1: Dieses Vergleichsdokument wurde nach bestem Wissen und Gewissen erstellt und ist rechtlich nicht bindend. Es gelten die von der EMA veröffentlichten Dokumente in der jeweiligen Form. Anmerkung
More informationVALIDATION OF ACTIVE PHARMACEUTICAL INGREDIENTS
VALIDATION OF ACTIVE PHARMACEUTICAL INGREDIENTS Second Edition Ira R. Berry Daniel Harpaz Editors ###5 Health Group *> MS-GHOUF Company Your Enterprise Solution for Global Healthcare Knowledge Denver,
More information3. Equipment Cleaning Validation for Active Pharmaceutical Ingredients (APIs) 8. Process Validation for Active Pharmaceutical Ingredients (API)
Title: Good Working Practice Validation Requirements Practice Number: 06 Prepared by: Date: Supersedes: Checked by: Date: Date Issued: Approved by: Date: Review Date: Topics: 1. Biological Test Methods
More informationValidation of Pharmaceutical Manufacturing Process Focus: APIs.
Validation of Pharmaceutical Manufacturing Process Focus: APIs Validations: Regulatory History (US FDA) Sterilisation 1977 Aseptic processing 1979 Water Systems 1981 Non-sterile Mfg Process 1987 Revised
More informationContents. Contents (13) 1 Production (23)
1 Production (23) 1.A Sanitation (27) 1.A.1 Organisational prerequisites (27) 1.A.2 Sources of contamination (28) 1.A.3 Responsibilities and implementation (29) 1.B Personnel hygiene (31) 1.B.1 Clothing
More informationTo Consultation Partners
EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Industrial affairs III: Consumer goods industries Pharmaceuticals and cosmetics Brussels, 30 October 1999 E-3 D(99) To Consultation Partners Subject :
More informationCleaning validation of cleanrooms and preparation equipments
Cleaning validation of cleanrooms and preparation equipments Dr Farshid SADEGHIPOUR Head of production Central Pharmacy, Geneva University Hospitals EAHP Foundation Seminar: Patient Safety; More About
More informationSystems-Based Inspections for Cleaning Validation
Systems-Based Inspections for Cleaning Validation FDA DG 230 March 21, 2016 Gaithersburg, MD Destin A. LeBlanc Cleaning Validation Technologies w w w.cleaningvalidation.com 1 Objectives Describe and/or
More informationCleaning / Cleaning Validation Update on toxicological approach
Cleaning / Cleaning Validation Update on toxicological approach Paul Sexton, Sarah O Meara, Denise Coakley GMP Conference 12th November 2014 Content Section I - Introduction Section II Toxicological Tool
More informationOverview of Regulatory Requirements for API and Formulations
Overview of Regulatory Requirements for API and Formulations Sangeeta Sardesai 4-Dec-2010 Definition - Regulatory Requirement The restrictions, licenses, and laws applicable to a product or business, imposed
More informationEUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Medicinal Products Quality, Safety and Efficacy Brussels, 6 February 2014 SANCO/TSE/ The received contributions together with the identity of
More informationGuidelines for Process Validation of Pharmaceutical Dosage Forms
Guidelines for Process Validation of Pharmaceutical Dosage Forms Version 2.1 Date issued 21/02/2010 Date of implementation 21/05/2010 31 August 2010 Page 1 of 20 Guidelines for Process Validation of Pharmaceutical
More informationGMP On Site Series. GMP Essentials
GMP On Site Series GMP Essentials GMP Basics Objectives 1. State the critical definitions of the pharmaceutical industry. 2. Describe the law as it applies to various critical functions. 3. State the history
More informationHealth Products and Food Branch Inspectorate Graham Spry Building, 3 rd Floor 250 Lanark Avenue Address Locator # 2003D OTTAWA, Ontario K1A 0K9 January 4, 2008 07-128997-672 TO: ALL INTERESTED PARTIES
More informationSince Annex 15 is not intended to cover APIs therefore the reference to ICH Q 11 does not make sense. (see comment 1) Expert Group May 2014
EU-GMP ANNEX 15 "Draft of 06.02.2014 - COMMENTS of the German Expert Group 10 "Qualification/Validation" Comment sent to ADM-GMDP@ema.europa.eu and sanco-pharmaceuticals-d6@ec.europa.eu by End of May 2014
More informationProcess development and basic GMP
Process development and basic GMP Aulton Chapter 45, handouts Specification, stability, inprocess controls and validation Product development Process development Critical Product Qualities issues Critical
More informationRegistered Starting Material Auditing Guide
Registered Starting Material Auditing Guide Annex 1 Aide Mémoire Company : Auditor(s) : Location, Country : Date of Audit: APIC Guide for Auditing Registered Starting Material Manufacturers Remark: Non-compliance
More informationGMP Inspection Deficiencies Review of Deficiencies Observed in 2013.
GMP Inspection Deficiencies 2013 Review of Deficiencies Observed in 2013. Executive Summary The most frequently encountered defect categories raised over the previous five years have remained relatively
More informationEUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union Volume 4
EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 03 February 2010 ENTR/F/2/AM/an D(2010) 3374 EudraLex The Rules Governing Medicinal Products in
More informationUNITED STATES DEPARTMENT OF AGRICULTURE FOOD SAFETY AND INSPECTION SERVICE WASHINGTON, DC AVAILABILITY OF CLEANING FREQUENCY QUESTIONS AND ANSWERS
UNITED STATES DEPARTMENT OF AGRICULTURE FOOD SAFETY AND INSPECTION SERVICE WASHINGTON, DC FSIS NOTICE 27-06 4/19/06 AVAILABILITY OF CLEANING FREQUENCY QUESTIONS AND ANSWERS The Food Safety and Inspection
More informationIJPRD, 2013; Vol 5(05): July-2013 ( ) International Standard Serial Number
IJPRD, 2013; Vol 5(05): July-2013 (001 008) International Standard Serial Number 0974 9446 --------------------------------------------------------------------------------------------------------------------------------------------------
More informationControl strategy and validation. Emanuela Lacana PhD Office of Biotechnology Products CDER/FDA
Control strategy and validation Emanuela Lacana PhD Office of Biotechnology Products CDER/FDA 1 Disclaimer The views and opinions expressed in this presentation are those of the speaker and should not
More informationSITE MASTER FILE For MHRA
ABC CO., LTD. For MHRA Prepared by Date Approved by Date Verified by Date Document No.: SMF, Version No: 01, Effective Date: 09/05/06 Document No.: SMF Version No.: 01 Effective Date: 09/05/06 Page 2 of
More informationEudraLex. Part I1 Chapter 6: Quality Control
EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 EU Guidelines tofor Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use Part I1 Chapter 6: Quality
More informationINTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND LIFE SCIENCES
B. Venkateswara Reddy et al IJRPLS, 2014, 2(2): 236-247 Review Article Available online at www.pharmaresearchlibrary.com/ijrpls ISSN: 2321-5038 INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND LIFE SCIENCES
More informationWHO GUIDELINE Stability testing of active pharmaceutical ingredients and finished pharmaceutical products
WHO GUIDELINE Stability testing of active pharmaceutical ingredients and finished pharmaceutical products 1. Introduction 1.1 Objectives of these guidelines 1.2 Scope of these guidelines 1.3 General principles
More informationEquipment Design Consideration for Cleaning & Cleaning Validation
Equipment Design Consideration for Cleaning & Cleaning Validation Gamal Amer, Ph. D. Principal Premier Compliance Services, Inc. All rights reserved. Do not copy without permission. 1 Cleaning and Cleaning
More informationKey-points of Post approval variation in Korea
7 th APAC, April 10, 2018 Key-points of Post approval variation in Korea Eunkyung Kim, Ph.D. Drug Evaluation Department, NIFDS, MFDS Disclaimer The information in this presentation is based on my experience.
More informationGUIDELINE FOR THE STABILITY TESTING
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 GUIDELINE FOR THE STABILITY TESTING OF NON-PRESCRIPTION (OTC)
More informationValidation Planning SOP
1.0 Commercial in Confidence 03-Aug-2006 1 of 10 Validation Planning SOP Document No: SOP_0300 Prepared by: David Brown Date: 03-Aug-2006 Version: 1.0 1.0 Commercial in Confidence 03-Aug-2006 2 of 10 Document
More informationThe validation of biological Active Pharmaceutical
This article presents a procedure for the validation of biological API manufacturing processes. It details each step of the procedure for biological processes applications, and covers the regulatory requirements
More informationCGMP for Phase 1 INDs
CGMP for Phase 1 INDs Laurie P. Norwood Deputy Director Division of Manufacturing and Product Quality Office of Compliance and Biologics Quality Center for Biologics Evaluation and Research 1 Overview
More informationPROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS VALIDATION
1 Working document QAS/13.527/Rev.2 August 2014 RESTRICTED 2 3 4 5 6 7 8 9 10 PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS
More informationFDA's Perspectives on Cross- Contamination in CMO Facilities, Considering High Risk Products
FDA's Perspectives on Cross- Contamination in CMO Facilities, Considering High Risk Products Bo Chi, Ph.D. Biotech Manufacturing Assessment Branch DGMPA/OMPQ/OC/CDER 1 Outline Regulatory framework Regulatory
More informationValidation Needs for Sterilization by Aseptic Filtration
Validation Needs for Sterilization by Aseptic Filtration DCVMN Workshop, Hyderabad, 4-8 April 2016 Ramesh Raju Associate Director - Provantage Validation Services Overview Key Regulatory and Industry guidelines
More informationEffective Management and Operations of GXP Laboratories
Effective Management and Operations of GXP Laboratories Course Objective: Upon completion of this course, attendees involved in establishing and assuring that Good Laboratory / Good Manufacturing Practice
More informationPrequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer
Prequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT API Manufacturer WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer Part 1: General information Name of Manufacture Unit number
More informationA Survey of Cleaning Validation General Principles and Best Practices
A Survey of Cleaning Validation General Principles and Best Practices International Workshop on "Vaccine Quality Management July 10-11th 2013 Hosted by Birmex, Mexico D.F. John Cyganowski EMD Millipore
More informationPHARMACEUTICAL DEVELOPMENT
CONTENTS PHARMACEUTICAL DEVELOPMENT Table of Acronyms - Abbreviations Introduction Preface Forward VIII XIII XV XVI XVII Chapter 1 Regulatory 1.1 - Pre-formulation checklist 1.3 Documentation 1.4 - SOP
More informationHealth Products and Food Branch Inspectorate
OUR MANDATE: To promote good nutrition and informed use of drugs, food, medical devices and natural health products, and to maximize the safety and efficacy of drugs, food, natural health products, medical
More informationGUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART II
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PE 009-8 (Part II) 15 January 2009 GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART II Developed by the
More information21CFR Ventilation, air filtration, air heating and cooling. 21CFR211 Details, Details. 21CFR Equipment Cleaning and Maintenance
21CFR211 Details, Details Kirsten L. Vadheim, Ph.D., RAC 7710 196th Avenue N.E. Redmond WA 98053 Tel: 651.260.6560 Fax: 425.868.4302 klvadheim@hotmail.com 21CFR211.46 Ventilation, air filtration, air heating
More informationGMP & Quality Assurance. Mayur Sushir Dept of Microbiology MJC
GMP & Quality Assurance Mayur Sushir Dept of Microbiology MJC Introduction GMP ensures that quality is built into the organization & processes involved in manufacture GMP covers all aspects of manufacture
More informationEUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union
EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 03 October 2005 EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 EU
More informationDrug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel
Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel On February 13th, 2006, the FOOD AND DRUG ADMINISTRATION (FDA) implemented a revision to the Compliance Program Guidance Manual for active
More informationEstablishing A Cleaning Method Validation Programme of Solid Dosage form of A Finished Drug Product
Available online on www.ijpqa.com International Journal of Pharmaceutical Quality Assurance 2016; 7(2); 29-34 Research Article ISSN 0975 9506 Establishing A Cleaning Method Validation Programme of Solid
More informationANDAs: Stability Testing of Drug Substances and Products- Industry Perspective
GPhA/FDA FALL TECHNICAL CONFERENCE ANDAs: Stability Testing of Drug Substances and Products- Industry Perspective Nick Cappuccino, Jr., Ph.D., Vice President Scientific Affairs, Dr. Reddy s Laboratories,
More informationEUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union
EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 25 October 2005 EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 EU
More informationDriving Value through Innovation in Biotech Manufacturing. Agenda
Driving Value through Innovation in Biotech Manufacturing Jorg Thommes, PhD Senior Vice President Operations Technology and Innovation Biogen 7 October 2015 Agenda Biopharma Legacy, Trends, & Challenges
More informationAudit Validation Programs Like a Champ (When your time is limited!!) Cathelene Compton 12 October 2017
Audit Validation Programs Like a Champ (When your time is limited!!) Cathelene Compton 12 October 2017 FDA 483 Observations 2 FDA 483 Observations 3 FDA 483 Observations 4 Auditing Validation How to cover
More information22 January Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, rm Rockville, MD 20852
22 January 2009 Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, rm. 1061 Rockville, MD 20852 SUBMISSION OF COMMENTS, DOCKET NO. FDA-2008-D-0559 Dear Sir or Madam:
More informationEUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union
Ref. Ares(2014)968036-28/03/2014 EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products quality, safety and efficacy Brussels, 28 March 2014 EudraLex
More informationNotice. This and other Guidance documents are available on the Health Canada website (
June 10, 2016 Notice Our file number: 16-106660-852 Adoption of International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Guidance:
More informationHISTORY AND MILESTONES
HISTORY AND MILESTONES HISTORY AND MILESTONES DOC S.r.l., Documentation Organization & Consultancy, was established in 1997 by MASCO group C.E.O. Eng. Alberto Borella and Eng. Paolo Curtò who became Managing
More informationGood Manufacturing Practices Purpose and Principles of GMP. Tony Gould
Good Manufacturing Practices Purpose and Principles of GMP Tony Gould Why GMP? Provides a high level assurance that medicines are manufactured in a way that ensures their safety, efficacy and quality Medicines
More informationPrequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Tablets
Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer Part 1: information about the inspection Name of manufacturer Physical address production departments
More informationThe next preventive control category to be discussed during this course is the sanitation controls.
The next preventive control category to be discussed during this course is the sanitation controls. The goals for this module are to describe 1) the difference between sanitation CGMPs and sanitation controls,
More informationPROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS VALIDATION
1 Working document QAS/13.527/Rev.1 April 2014 RESTRICTED 2 3 4 5 6 7 8 9 10 PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS
More informationCleaning Validation Systems CIP COP Manual How to get to Validation
Cleaning Validation Systems CIP COP Manual How to get to Validation First: Know and Understand the Soils and Residues You Must Clean Virus 3 Raw Meat and Prions 4 Formalin Sodium Citrate Sucrose Triton
More informationFor. EDS Tech Training Sites System. Volume 1. Introduction to the EDS Tech Training Sites System. Standard Operating Procedures
STANDARD OPERATING PROCEDURES (SOP) For EDS Tech Training Sites System Volume 1 Introduction to the EDS Tech Training Sites System Standard Operating Procedures EDS Tech Training Sites January 2011 SECTION
More informationThe next preventive control category to be discussed during this course is the sanitation controls.
The next preventive control category to be discussed during this course is the sanitation controls. 1 The goals for this module are to describe 1) the difference between sanitation CGMPs and sanitation
More informationElectrocoagulation. Variable Electro Precipitation. Athena Global Energy Solutions
Electrocoagulation Variable Electro Precipitation Overview What is electro-coagulation? Process Flow & Treatment Results Percent (%) Removal Applications Capabilities Benefits Container & Trailer Mounted
More informationBasic Principles of GMP. Sanitation and Hygiene
Basic Principles of GMP Sanitation and Hygiene Module 3 Slide 1 of 26 Objectives Review measures to ensure good sanitation in: premises equipment processes To review measures to ensure good personnel hygiene
More informationSubject: EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use, Annex 15: Qualification and Validation
29 May 2014 EUROPEAN COMMISSION Health and Consumers Directorate-General Subject: EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use, Annex 15: Qualification
More informationINDUSTRIAL PROCESS VALIDATION OF TABLET DOSAGE FORM: A REVIEW
International Journal of Pharmacy Review & Research www.ijprr.com INDUSTRIAL PROCESS VALIDATION OF TABLET DOSAGE FORM: A REVIEW Vishal Sharma* and Nimrata Seth 1 Department of Pharmaceutics, Rayat Institute
More informationOverview Engineering Unit
Overview Engineering Unit 2016 Montgomery County Community College Biomanufacturing Engineering Requirements A successful and productive biomanufacturing facility must meet and adhere to certain engineering
More informationFOOD AND DRUGS AUTHORITY
G H A N A FOOD AND DRUGS AUTHORITY GUIDELINES FOR STABILITY TESTING OF ACTIVE PHARMACEUTICAL INGREDIENTS AND FINISHED PHARMACEUTICAL PRODUCTS Document No: FDA/DRI/DER/GL-STP/2013/07 Date of First Adoption:
More informationLibrary Guide: Active Pharmaceutical
Library Guide: Active Pharmaceutical Ingredients (API) Table of Contents Overview...3 Sample Curriculum...5 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)...7 A Tour of the
More informationSubpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit.
FDA inspections continue to focus on CGMP violations related to basic GMP controls. A survey of Warning Letters issued in 2013 on CMC (Chemistry / Manufacturing / Controls) violations reveals an emphasis
More informationQuality Assessment & GMP Similarities & Differences
Quality Assessment & GMP Similarities & Differences EMEA, Monday 26 th October 2009 Cormac Dalton Inspector Irish Medicines Board Date 12-Oct-09 Slide 1 Content Overview of commonalities & differences
More informationProcess validation in medical devices
Process validation in medical devices Fulfil requirements with expert regulatory guidance 1TÜV SÜD Contents INTRODUCTION 4 VALIDATION PLANNING 5 INSTALLATION QUALIFICATION 7 OPERATIONAL QUALIFICATION 9
More informationProcess validation in medical devices
Process validation in medical devices Fulfil requirements with expert regulatory guidance 1TÜV SÜD Contents INTRODUCTION 4 VALIDATION PLANNING 5 INSTALLATION QUALIFICATION 7 OPERATIONAL QUALIFICATION 9
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Inspections, Compliance, Enforcement, and Criminal Investigations Nostrum Laboratories Inc 4/27/09 Department of Health and Human Services Public Health Service Food and Drug Administration Kansas City
More informationDr. Sheelpriya walde Professor Gurunanak college of pharmacy, Nagpur
Dr. Sheelpriya walde Professor Gurunanak college of pharmacy, Nagpur GMP ( Adopted in 1975 ) In India Good manufacturing practices are the practices required in order to conform to guidelines recommended
More informationBest Practices For Cleaning Validation in the Aseptic Environment SUMMARY OF OUTLINE
Best Practices For Cleaning Validation in the Aseptic Environment Vivienne Yankah, PhD, CQE sanofi pasteur Ltd. Toronto, Canada SUMMARY OF OUTLINE Review Regulatory Standards for CV Designing and Developing
More informationSTRATEGIES FOR CLEANING
STRATEGIES FOR CLEANING AND CLEANING VALIDATION THAT MINIMIZE DOWNTIME FOR PRODUCT CHANGEOVERS JOHN HYDE HYDE ENGINEERING + CONSULTING PRESENTATION OUTLINE Importance of Cleaning Process Development at
More informationThe World Bank. Aide Memoire for use during GMP inspections
The World Bank e for use during GMP inspections The World Bank Procurement of Health Sector Goods Contact persons: 0 1. General information about the manufacturer Name of manufacturer Physical address
More informationAnnex 4. Guidance on good manufacturing practices: inspection report. Background
Annex 4 Guidance on good manufacturing practices: inspection report Background The need for revision of the Guidance on good manufacturing practices: inspection report (World Health Organization (WHO)
More informationDRAFT: FSSC FSMA Comparison
http://www.achesongroup.com jennifer@achesongroup.com 301-551-3601 December 2013 DRAFT: FSSC 22000 FSMA Comparison Scope of Evaluation and Summary This evaluation was done to demonstrate how FSSC 22000
More informationSTABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS
More informationGood Manufacturing Practice for Advanced Therapy Medicinal Products
Good Manufacturing Practice for Advanced Therapy Medicinal Products Answers to questions Q1 to Q25, as referenced in the text: General remark. We support the idea of an ATMP-specific guideline and most
More informationGUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PE 009-11 (Intro) 1 March 2014 GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PIC/S March 2014 Reproduction
More informationPrequalification of Medicines Programme
Prequalification of Medicines Programme SOP 408.4 Annex A WHO PUBLIC INSPECTION REPORT Finished Product Manufacturer WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer Part 1: General
More informationPrequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer
Prequalification of Medicines Programme SOP 408.4 Annex B WHO PUBLIC INSPECTION REPORT API Manufacturer Part 1: General information Name of Manufacturer Unit number WHO PUBLIC INSPECTION REPORT (WHOPIR)
More informationSUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES (GMP): VALIDATION
Pharmapathway.com SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES (GMP): VALIDATION Page 1 of 43 1. INTRODUCTION Validation is an essential and integral part of Good Manufacturing Practice (GMP).
More informationSupplementary Training Modules on Good Manufacturing Practice. Validation. WHO Technical Report Series, No. 937, Annex 4.
Supplementary Training Modules on Good Manufacturing Practice Validation WHO Technical Report Series, No. 937, 2006. Annex 4. Validation Slide 1 of 48 August 2006 Validation! Part 1. General overview on
More informationAPI Stability Protocols and. Chris Byrne Tasmanian Alkaloids
API Stability Protocols and Evaluations Chris Byrne Tasmanian Alkaloids API Stability Overview APIs = 100% pure Limited (if any) degradation No interactions with other agents in drug products Less likelihood
More information